Peihong Wu

9PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 05, 2025
Using Machine Learning to Predict Advanced-Stage Progression of Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization.

Ran Wei, Zelong Liu, Lingjie Ju

|Feb 03, 2025
Correction: Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study.

Chao An, Ran Wei, Wendao Liu

|Jul 06, 2024
Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study.

Chao An, Ran Wei, Wendao Liu

|May 31, 2024
Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study.

Chao An, Ran Wei, Wang Yao

|Apr 08, 2023
Postprogression treatment of lenvatinib plus PD-1 inhibitor in advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy.

Chao An, Yan Fu, Wang Li

|Oct 23, 2019
Radiofrequency Ablation Following Downstaging of Hepatocellular Carcinoma by Using Transarterial Chemoembolization: Long-term Outcomes.

Feng Shi, Ming Wu, Shan-Shan Lian

Pageof 2

Frequent Collaborators

3 joint publications

Chao An

2 joint publications

Wang Li

2 joint publications

Dong Yan

2 joint publications

Wang Yao